Catalyst Pharmaceuticals Inc (CPRX) — Strategic Asset Allocation Index
Catalyst Pharmaceuticals Inc (CPRX) has a Strategic Asset Allocation Index of 2.7% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $27.29 Million) total $27.29 Million, measured against net assets of $1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Catalyst Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Catalyst Pharmaceuticals Inc Strategic Asset Allocation Index (2004–2025)
This chart shows how Catalyst Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the index stands at 2.7%, representing strategic assets of $27.29 Million against net assets of $1.01 Billion USD. For live market cap and overall valuation, see Catalyst Pharmaceuticals Inc (CPRX) market capitalisation.
Annual Strategic Asset Allocation Index for Catalyst Pharmaceuticals Inc (2004–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Catalyst Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Catalyst Pharmaceuticals Inc (CPRX) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 2.4% | $22.54 Million | $- | $22.54 Million | $954.27 Million | ▼ -0.6 pp |
| 2024 | 3.0% | $21.56 Million | $- | $21.56 Million | $727.63 Million | ▼ -1.3 pp |
| 2023 | 4.3% | $16.49 Million | $- | $16.49 Million | $387.88 Million | ▲ +4.0 pp |
| 2022 | 0.3% | $847.00K | $847.00K | $0.00 | $300.42 Million | ▼ -1.6 pp |
| 2021 | 1.9% | $3.98 Million | $3.98 Million | $- | $206.83 Million | ▲ +1.8 pp |
| 2020 | 0.1% | $129.80K | $129.80K | $- | $169.60 Million | ▼ -0.2 pp |
| 2019 | 0.2% | $210.47K | $210.47K | $0.00 | $87.63 Million | ▼ -10.1 pp |
| 2018 | 10.3% | $5.25 Million | $245.43K | $5.01 Million | $50.78 Million | ▲ +10.1 pp |
| 2017 | 0.2% | $191.38K | $191.38K | $- | $80.96 Million | ▼ -0.4 pp |
| 2016 | 0.6% | $244.20K | $244.20K | $- | $39.31 Million | ▲ +0.3 pp |
| 2015 | 0.3% | $191.55K | $191.55K | $- | $55.48 Million | ▲ +0.1 pp |
| 2014 | 0.2% | $71.38K | $71.38K | $- | $35.24 Million | ▲ +0.0 pp |
| 2013 | 0.2% | $40.63K | $40.63K | $- | $21.39 Million | ▼ -0.2 pp |
| 2012 | 0.4% | $53.68K | $53.68K | $- | $14.62 Million | ▲ +0.0 pp |
| 2011 | 0.3% | $12.19K | $12.19K | $- | $3.76 Million | ▼ -0.5 pp |
| 2010 | 0.8% | $45.00K | $45.00K | $- | $5.52 Million | ▼ -0.1 pp |
| 2009 | 0.9% | $68.00K | $68.00K | $- | $7.62 Million | ▼ 0.0 pp |
| 2008 | 0.9% | $96.00K | $96.00K | $- | $10.56 Million | ▲ +0.1 pp |
| 2007 | 0.8% | $128.00K | $128.00K | $- | $16.32 Million | ▲ +0.7 pp |
| 2006 | 0.1% | $20.00K | $20.00K | $- | $19.85 Million | ▼ -0.8 pp |
| 2005 | 0.9% | $4.00K | $4.00K | $- | $446.46K | ▲ +0.0 pp |
| 2004 | 0.9% | $1.00K | $1.00K | $- | $117.58K | — |